Related Publications

2018SurvSummThumbnail

Annual Surveillance Report of Drug-Related Risks and Outcomes – United States, 2019pdf icon

Summarizes the latest information available for various health outcomes, health behaviors, and prescribing patterns related to the drug problem in the United States. This report covers latest data available on rates of opioid prescribing, substance use disorder, nonfatal hospitalizations and emergency department visits, and overdose deaths. National information, and some state information, is presented to serve as a resource to help address the ongoing national problem of drug abuse, addiction, and overdose.

2019 2018SurvSummThumbnail

Highlights from the Annual Surveillance Report of Drug-Related Risks and Outcomes – United States, 2019pdf icon

Presentation available for download, and includes highlights of the data, maps, tables, and charts from the second Annual Surveillance Report of Drug-Related Risks and Outcomes – United States.  Citation when using resources from this presentation [Centers for Disease Control and Prevention. 2019 Annual Surveillance Report of Drug-Related Risks and Outcomes — United States. Surveillance Special Report. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Published November 1, 2019.

CDC Health Alert Network (HAN) Advisories

CDC Grand Rounds

NCHS Data Publications

Other Publications

  • A promising strategy for addressing the U.S. opioid overdose epidemic is improving the use of prescription drug monitoring programs (PDMPs). The Substance Abuse and Mental Health Services Administration (SAMHSA) funded nine states to better integrate PDMP data into health systems and to initiate and increase interstate data sharing. The project was called PDMP Electronic Health Records (EHRs) Integration and Interoperability Expansion (PEHRIIE) and funded Florida, Illinois, Indiana, Kansas, Maine, Ohio, Texas, Washington, and West Virginia from 2012 to 2016. CDC conducted a process and outcome evaluation of the program; and in collaboration with Brandeis University, used a comparative case study to describe the implementation process, identify successes and challenges, and explore the program’s effects on the stated goals.

  • Created by the Department of Health and Human Services’ Behavioral Health Coordinating Committee Subcommittee on Prescription Drug Abuse, this publication is a review of current federal initiatives and literature focused on ensuring the safe use of prescription drugs with the potential for abuse and the treatment of prescription drug dependence. The report includes identified opportunities to enhance programmatic and policy efforts as well as future research on prescription drug abuse and overdose in the U.S. (This publication was developed pursuant to Section 1122 of the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA)external icon.)

  • References
    Prescription Painkiller Overdoses is one in a series of issue briefs highlighting key public health issues and important, science-based policy actions that can be taken to address them. Through this publication, CDC supports state-based efforts to reduce prescription drug abuse while ensuring patients have access to safe, effective pain treatment. The publication includes information about deaths and emergency department visits resulting from prescription painkiller overdoses, overdose trends, the most common drugs involved, and the regions and populations most severely affected. Recommendations on how health care providers, private insurance providers, and state and federal agencies can work to prevent unintentional drug overdoses are also included.

  • To assess the knowledge, response, and planning regarding prescription drug misuse and overdose, in late 2007 the Association of State and Territorial Health Officials (ASTHO) and CDC conducted interviews with state and territorial health officials and other senior leaders in nine states (Arkansas, Florida, Indiana, Kentucky, Montana, North Carolina, Oklahoma, Utah, and West Virginia). The resulting report, Prescription Drug Overdose: State Health Agencies Respond, outlines the state perceptions, partnerships, recommendations, policies, and other issues that are fundamental to understanding and responding to drug misuse.

CDC Guideline for Prescribing Opioids for Chronic Pain